Erythrocyte-Mediated Drug Delivery for the Prevention of Stent Restenosis

Clinical trial NCT00484965 · UNKNOWN

Trial details

NCT number: NCT00484965
Sponsor: University of Rome Tor Vergata
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Atherosclerosis Acute-Phase Reaction

Start date: 2007-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.